<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230705058678N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-08-27</date_registration>
      <primary_sponsor>Isfahan Cardiovascular Research Institute</primary_sponsor>
      <public_title>Comparison of hybrid and center-based cardiac rehabilitation</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation and comparison of the effectiveness of a 12-session center-based cardiac rehabilitation course with a hybrid form of cardiac rehabilitation course on changes in myocardial function indices, risk factors and quality of life in patients with ischemic heart disease</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-08-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>126</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/71106</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Randomization will be conducted through tables of random numbers and by computers that generate numbers randomly. The table of random numbers to be used is produced by the RAND Corporation (www.rand.org). These tables have random numbers in both row and column directions. First, all patients' names will be numbered. Then, the researcher selects a random number from the table of random numbers for selecting individuals in the intervention group. After selecting one number randomly, the researcher moves either in the row or column direction and sequentially chooses the next individuals until the last person in the intervention group is determined. The remaining individuals will be assigned to the control group, Blinding description: Patients are randomly assigned to two groups, hybrid and center-based, and the clinical observer records the relevant information after conducting the intervention. Then, without specifying the name of each group (as A and B), this information is provided to the researcher and analyzer in a file. The analyzer and researcher remain unaware of which group the data corresponds to.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Cardiac rehabilitation.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In this group, cardiac rehabilitation will be conducted through 6 sessions at the center and another 6 sessions at home. Each cardiac rehabilitation exercise session at the center will last for 60 minutes and will include stretching and low-intensity exercises for warming up, lasting 5 to 10 minutes. Then, the main exercise regimen for the patient will be performed using exercise equipment such as ergometers and treadmills, followed by 5 to 10 minutes of cool-down exercises for recovery. During the 6-session rehabilitation course conducted at home, participants will receive educational instructions on healthy nutrition, risk factor control, as well as engage in physical activities provided through instructional CDs. Participants' walking will be recorded using a pedometer, and their daily physical activity duration, intensity, and distance covered will be noted and evaluated using a daily physical activity log table. Intervention 2: Control group: In this group, 12 sessions of rehabilitation will be conducted at the center. Each cardiac rehabilitation exercise session at the center will last for 60 minutes and will include stretching and low-intensity exercises for warming up, lasting 5 to 10 minutes. Then, the main exercise regimen for the patient will be performed using exercise equipment such as ergometers and treadmills, followed by 5 to 10 minutes of cool-down exercises for recovery.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
After completing the study, the results comparing the intervention and control groups for each variable are published in an article and made available to the public. The individual participants' data files will be made available to researchers through a virtual server in a secure research environment (SRE). Researchers can access the raw data files in this environment after anonymizing the individuals and performing their analysis on them.

When:
The results of the study are accessible after the article is published. Access to the individual participants' data file will be possible for researchers 6 months after the publication of the article.

To whom:
The results of the study will be made available to the public in the form of an article. The raw data file will only be provided to researchers from reputable academic and scientific institutions.

Conditions:
These data will be made available to researchers for relevant studies or to complement previous research. Adherence to research ethics principles and the preservation of intellectual property rights are necessary for accessing the information.
Researchers can access and observe the raw data of the participants in a secure research environment (SRE) after anonymizing them, and they can perform statistical analysis on the data or generate reports based on it.

Where to obtain:
To access the data, researchers can contact the Cardiovascular Research Institute of Isfahan University of Medical Sciences.

Email: crc@mui.ac.ir
Phone number: 00983136115310
Address: Isfahan Cardiovascular Research Institute, Rahmani Alley, next to Chamran Cardiac Educational and Treatment Center, Moshtagh 3rd Street, Isfahan. 

Website: icri.mui.ac.ir

How to obtain:
1. Submitting a request by the researcher to the Research Deputy of the Cardiovascular Research Institute.
2. Approval of the request and signing a memorandum of understanding.
3. Setting up the SRE environment for the researcher.
4. Uploading the data and dictionary for observation and analysis.
5. Sending the final report and output to the researcher after the approval of the Research Deputy.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sina Rouhani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Cardiac Rehabilitation Research Center, Isfahan Cardiovascular Research Institute, Shahid Rahmani Alley, next to Shahid Chamran Hospital, Mushtaq 3rd St.</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8158388994</zip>
        <telephone>+98 31 3611 5208</telephone>
        <email>sn.rouhani@gmail.com</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Masoumeh Sadeghi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Cardiac Rehabilitation Research Center, Isfahan Cardiovascular Research Institute, Shahid Rahmani Alley, next to Shahid Chamran hospital, Mushtaq 3rd St.</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8158388994</zip>
        <telephone>+98 31 3611 5208</telephone>
        <email>sadeghimasoumeh@gmail.com</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The patient has been treated for ischemic heart disease in one of the hospitals in Isfahan City
At least two weeks have passed since PCI or 4 weeks since CABG
The minimum age for participation in the study is 30 years, and the maximum age is 80 years</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>80 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Contraindications for cardiac rehabilitation
Patients who do not consent to participate in the study
Physician's non-consent for patient's participation in the study.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I20.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Angina pectoris, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In this group, cardiac rehabilitation will be conducted through 6 sessions at the center and another 6 sessions at home. Each cardiac rehabilitation exercise session at the center will last for 60 minutes and will include stretching and low-intensity exercises for warming up, lasting 5 to 10 minutes. Then, the main exercise regimen for the patient will be performed using exercise equipment such as ergometers and treadmills, followed by 5 to 10 minutes of cool-down exercises for recovery. During the 6-session rehabilitation course conducted at home, participants will receive educational instructions on healthy nutrition, risk factor control, as well as engage in physical activities provided through instructional CDs. Participants' walking will be recorded using a pedometer, and their daily physical activity duration, intensity, and distance covered will be noted and evaluated using a daily physical activity log table.</i_keyword>
      <i_keyword>Control group: In this group, 12 sessions of rehabilitation will be conducted at the center. Each cardiac rehabilitation exercise session at the center will last for 60 minutes and will include stretching and low-intensity exercises for warming up, lasting 5 to 10 minutes. Then, the main exercise regimen for the patient will be performed using exercise equipment such as ergometers and treadmills, followed by 5 to 10 minutes of cool-down exercises for recovery.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Average functional capacity (METs) of patients based on exercise test. Timepoint: At the beginning of the study (prior to intervention) and at the end of the study after 12 rehabilitation sessions. Method of measurement: Exercise test.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Quality of life score based on MacNew questionnaire. Timepoint: At the beginning of the study (prior to intervention) and at the end of the study after 12 rehabilitation sessions. Method of measurement: MacNew questionnaire.</sec_outcome>
      <sec_outcome>Anxiety score in Spielberger questionnaire. Timepoint: At the beginning of the study (prior to intervention) and at the end of the study after 12 rehabilitation sessions. Method of measurement: Spielberger questionnaire.</sec_outcome>
      <sec_outcome>Depression score in Beck questionnaire. Timepoint: At the beginning of the study (prior to intervention) and at the end of the study after 12 rehabilitation sessions. Method of measurement: Beck questionnaire.</sec_outcome>
      <sec_outcome>The amount of physical activity based on the IPAQ questionnaire. Timepoint: At the beginning of the study (prior to intervention) and at the end of the study after 12 rehabilitation sessions. Method of measurement: IPAQ questionnaire.</sec_outcome>
      <sec_outcome>Smoking. Timepoint: At the beginning of the study (prior to intervention) and at the end of the study after 12 rehabilitation sessions. Method of measurement: Questionnaire.</sec_outcome>
      <sec_outcome>Serum level of Triglyceride. Timepoint: At the beginning of the study (prior to intervention) and at the end of the study after 12 rehabilitation sessions. Method of measurement: Testing the patient blood sample.</sec_outcome>
      <sec_outcome>The changes in systolic blood pressure. Timepoint: At the beginning of the study (prior to intervention) and at the end of the study after 12 rehabilitation sessions. Method of measurement: Sphygmomanometer.</sec_outcome>
      <sec_outcome>The changes in body mass index (BMI). Timepoint: At the beginning of the study (prior to intervention) and at the end of the study after 12 rehabilitation sessions. Method of measurement: Body mass index formula.</sec_outcome>
      <sec_outcome>Fasting blood sugar level. Timepoint: At the beginning of the study (prior to intervention) and at the end of the study after 12 rehabilitation sessions. Method of measurement: Testing the patient blood sample.</sec_outcome>
      <sec_outcome>The changes in diastolic blood pressure. Timepoint: At the beginning of the study (prior to intervention) and at the end of the study after 12 rehabilitation sessions. Method of measurement: Sphygmomanometer.</sec_outcome>
      <sec_outcome>Serum level of cholesterol. Timepoint: At the beginning of the study (prior to intervention) and at the end of the study after 12 rehabilitation sessions. Method of measurement: Testing the patient blood sample.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Isfahan Cardiovascular Research Institute</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-04-05</approval_date>
        <contact_name>Biomedical Ethics Research Committee of School of Medicine - Isfahan University of Medical Sciences</contact_name>
        <contact_address>Isfahan University of Medical Sciences, Hezar jarib ave. Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
